Business
AdAlta (ASX:1AD) share price rockets 31% on United States FDA update
The AdAlta Ltd (ASX:1AD) share price is rocketing today following the positive news on its drug trials. In mid-morning trade, the biotech company’s share price is soaring 31.4% higher to 23 cents.
However, at the time of writing, the AdAlta share price has retreated slightly to 20 cents, up 14.29%. Also, it’s worth noting that the AdAlta share price reached a 52-week high of 26.5 cents in the opening minutes of trade.
Quick take on AdAlta
Established in 2006, AdAlta is a clinical-stage biotechnology company. The company’s focus is on researching and developing protein-based therapies. Thus, AdAlta utilises a range of unique compounds, known as i-bodies, to create a pipeline of drugs to treat serious diseases. This includes…
-
General15 hours agoPublisher ditches David Walliams after harassment claim
-
General13 hours agoDreams shattered as 140 Zone RV caravan customers’ worst fears realised
-
General12 hours agoGrace Lillian Lee weaves a path from the Torres Strait to Paris
-
General15 hours agoRome to charge tourists to visit Trevi Fountain